Steering committee of pulmonary and primary care experts aims to reduce time to diagnose complex lung diseases
May 17, 2022 10:00 ET
|
American College of Chest Physicians
GLENVIEW, Ill., May 17, 2022 (GLOBE NEWSWIRE) -- The American College of Chest Physicians (CHEST) and Three Lakes Foundation are announcing a steering committee of experts in the fields of pulmonary...
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
March 30, 2022 16:05 ET
|
Angion Biomedica Corp.
-- Enrollment continues in Phase 2 JUNIPER trial of ANG-3070 for the treatment of patients with primary proteinuric kidney diseases -- Ended the year with nearly $89M in cash and cash equivalents ...
Global Idiopathic Pulmonary Fibrosis Disease Treatment Markets, 2018-2019 & 2020-2024
September 08, 2021 03:58 ET
|
Research and Markets
Dublin, Sept. 08, 2021 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Disease Treatment: Global Markets" report has been added to ResearchAndMarkets.com's offering.The current report...
Idiopathic Pulmonary Fibrosis (IPF) Clinical Landscape Report 2021 with 10-Year Disease Incidence and Prevalence Forecasts
July 13, 2021 05:13 ET
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Idiopathic pulmonary fibrosis (IPF)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers...
![CPF logo without tagline](/news-release/logo/322975/0/322975.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A58&size=2)
Coalition for Pulmonary Fibrosis to Cease Operations
November 19, 2015 10:25 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- "Never doubt that a small group of thoughtful, committed, citizens can change the world. Indeed, it is the only thing that ever has." -- Margaret...
MediciNova to Initiate Clinical Trial of MN-001 (tipelukast) in IPF
October 09, 2015 06:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., Oct. 09, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
![CPF logo without tagline](/news-release/logo/322975/0/322975.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A58&size=2)
SPORTS RADIO HOST, COMMERCIAL BANK VP, ST. JUDE, UTHSC DOCTORS, TEMPLE ISRAEL RABBI TO SPEAK AT BOTANIC GARDEN CEREMONY
July 16, 2015 14:29 ET
|
Coalition for Pulmonary Fibrosis (CPF)
MEMPHIS, Tenn., July 16, 2015 (GLOBE NEWSWIRE) -- A deadly lung disease most have never heard of is lurking in the community and threatening the lives of some well-known Memphians as it has claimed...
![CPF logo without tagline](/news-release/logo/322975/0/322975.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A58&size=2)
CPF Celebrates Historic Year of Progress in Pulmonary Fibrosis
December 30, 2014 14:05 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) played an important role in much of the year's successes in Pulmonary Fibrosis (PF), helping to make...
![Barbara Barrie photo](http://www.globenewswire.com/en/Attachment/LogoDisplay/314123?filename=314123.png&size=2)
CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 17:19 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In its press release dated October 16, 2014 at 10:46 AM EST with the headline "Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis...
![Barbara Barrie photo](http://www.globenewswire.com/en/Attachment/LogoDisplay/314090?filename=314090.png&size=2)
Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 10:46 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Patients, families and researchers alike have anticipated for months the U.S. Food and Drug Administration (FDA) decisions on two drugs for...